Although the Affordable Care Act eliminated OOP costs for screening mammograms under most insurance plans, that coverage does not carry over to the additional exams that are needed when abnormal findings are uncovered.
Hisashi Tachizaki, Canon’s current senior VP and chief marketing executive, will be heading the new U.S.-based Canon Medical subsidiary company as its president and CEO.
“The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022.
JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.
The use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are seeking when it comes to joint pain, according to new findings to be presented at RSNA 2022.
When lung cancer is caught in its early stages, long-term survival rates can reach 80% and higher, according to a new large-scale, 20-year international study presented at this year's RSNA meeting.
There are limited data to determine whether pancreatitis in COVID patients is the result of a stress response triggered by severe illness or by direct damage to the β-cell structure and function.
(A) Cerebral microbleeds (CMB) visualized as round, dark lesions (arrow) on SWI sequence in the left temporal lobe in a migraine case with aura. (B) Asymmetry in the appearance of the cortical vessels is more prominent on the left side (arrow) ipsilateral to the CMB. Images courtesy of RSNA.
In a new analysis, scheduled to be presented at RSNA 2022 in Chicago, researchers have identified enlarged perivascular spaces in the brains of migraine patients. This may be suggestive of waste clearance issues in the central nervous system.
An example of a lung cancer found using low-dose computed tomography (LDCT). Image courtesy of RSNA
A new partnership between Sirona Medical and RevealDX could streamline the process of AI integration into the clinical practice of lung nodule assessments.
The study's authors explained how MRI results can be used to help identify children with ADHD—and how these findings could be used in the AI algorithms of tomorrow. The team will be presenting its findings at RSNA 2022 in Chicago.
